2016:15:00- 2016: Trump's '100% Tax Bill'

Illustration. (Photo: Doc. East Java Provincial Government)

JAKARTA - An independent vaccine program labeled Gotong Royong vaccination is known to begin this month. In the program the price offered is Rp1 million for two doses of injection.

Chairman of the Indonesian Chamber of Commerce and Industry (Kadin) Rosan Roeslani said the value of vaccination is considered to still be met by entrepreneurs. The assumption is based on an internal kadin survey that says that 78 percent of business owners are able to meet vaccinations for workers.

"It's still okay, we've not burdened the survey," he said as quoted on Monday, May 10.

Rosan instead gave another positive signal by revealing that businesses can bear the cost of vaccination entirely without expecting subsidies from the government.

"We don't plan to ask for subsidies from the government," he said.

To be known, the cost of Rp1 million is the funds used for the procurement of vaccines in two injections as well as the cost of vaccinators, doctors, and other medical personnel.

"The vaccine itself is Sinopharm," he said.

To be known, the Gotong Royong vaccination program will be gloriously conducted on May 18, targeting workers whose costs are borne by the company.

"There should be no commercialization," said the Head of Kadin.

In fact, the cost can be cheaper to Rp750,000 if the company has its own representative health facilities, such as hospitals complete with doctors and medical personnel.

"If you have your own health facilities can be cheaper, but must really meet the requirements of the Ministry of Health ,"He explained.

Gotong Royong vaccination program targets the number of recipients 7.5 million people until September 2021 with the first orientation of 187,000 people on May 18.

Based on data released by the Ministry of Health, until May 9, the number of people who have received the first dose of vaccine is recorded as 13,340,957 people. The number of recipients of the second dose as many as 8,634,546 people.